CoChat

Modeling of signaling crosstalk-mediated drug resistance and its implications on drug combination

Open access
Sun, Xiaoqiang, Bao, Jiguang, You, Zhuhong, Chen, Xing, Cui, Jun · 2016 · Oncotarget
Cited by 60

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Xiaoqiang Sun 1, 2, 3 , Jiguang Bao 4 , Zhuhong You 5 , Xing Chen 6 , Jun Cui 3, 7 1 Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China 2 School of Mathematical and Computational Science, Sun Yat-Sen University, Guangzhou, 510000, China 3 School of Life Science, Sun Yat-Sen University, Guangzhou, 510275, China 4 School of Mathematical Sciences, Beijing Normal University, Beijing, 100875, China 5 School of Computer Science and Technology, China University of Mining and Technology, Xuzhou, 221116, China 6 School of Information and Electrical Engineering, China University of Mining and Technology, Xuzhou, Jiangsu, 221116, China 7 Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University, Guangzhou, 510060, China Correspondence to: Xiaoqiang Sun, email: xiaoqiangsun88@gmail.com , dongbusun@163.com Xing Chen, email: xingchen@amss.ac.cn Jun Cui, email: cuij5@mail.sysu.edu.cn Keywords: signaling crosstalk, drug resistance, drug combination, synergism Received: June 16, 2016 Accepted: August 26, 2016 Published: August 31, 2016 ABSTRACT The efficacy of pharmacological perturbation to the signaling transduction network depends on the network topology. However, whether and how signaling dynamics mediated by crosstalk contributes to the drug resistance are not fully understood and remain to be systematically explored. In this study, motivated by a realistic signaling network linked by crosstalk between EGF/EGFR/Ras/MEK/ERK pathway and HGF/HGFR/PI3K/AKT pathway, we develop kinetic models for several small networks with typical crosstalk modules to investigate the role of the architecture of crosstalk in inducing drug resistance. Our results demonstrate that crosstalk inhibition diminishes the response of signaling output to the external stimuli. Moreover, we show that signaling crosstalk affects the relative sensitivity of drugs, and some types of crosstalk modules that could yield resistance to the targeted drugs were identified. Furthermore, we quantitatively evaluate the relative efficacy and synergism of drug combinations. For the modules that are resistant to the targeted drug, we identify drug targets that can not only increase the relative drug efficacy but also act synergistically. In addition, we analyze the role of the strength of crosstalk in switching a module between drug-sensitive and drug-resistant. Our study provides mechanistic insights into the signaling crosstalk-mediated mechanisms of drug resistance and provides implications for the design of synergistic drug combinations to reduce drug resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.11745

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Sun, X., Bao, J., You, Z., Chen, X., & Cui, J.
Venue
Oncotarget
Published
2016-08-31
Volume
7
Issue
39
Pages
63995-64006
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2518259126
Cited by
60
References
7
FWCI
6.13
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.